Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F2 | P00734 | 2/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | HTR1A | P08908 | 3/20 | 0.44 |
| ▸ | HTR7 | P34969 | 3/20 | 0.44 |
| ▸ | TACR1 | P25103 | 1/20 | 0.41 |
| ▸ | CASP3 | P42574 | 1/20 | 0.40 |
| ▸ | CASP7 | P55210 | 1/20 | 0.40 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.39 |
| ▸ | S100A4 | P26447 | 1/20 | 0.39 |
| ▸ | PRCP | P42785 | 1/20 | 0.39 |
| ▸ | ACE | P12821 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26426189 | 0.91 | HTR1A (0.46) | F2POLBHTR1AHTR7TACR1 | |
| SCHEMBL26429166 | 0.86 | F2 (0.48) | F2HTR1AHTR7 | |
| SCHEMBL26418988 | 0.84 | PREP (0.45) | F2 | |
| SCHEMBL26429177 | 0.83 | F2 (0.58) | F2POLBACE | |
| SCHEMBL26429154 | 0.81 | F2 (0.53) | F2POLBPRCP | |
| SCHEMBL26424878 | 0.81 | F2 (0.48) | F2 | |
| SCHEMBL26428633 | 0.81 | F2 (0.64) | F2HTR1AHTR7TAAR1ACE | |
| SCHEMBL26426169 | 0.80 | F2 (0.52) | F2HTR1AHTR7PRCPACE | |
| SCHEMBL26427890 | 0.80 | DPP4 (0.44) | F2HTR1AHTR7ACE | |
| SCHEMBL26428651 | 0.79 | FAP (0.46) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023072971-A2 | GASTRIC INHIBITORY PEPTIDE RECEPTOR LIGANDS | 3B PHARMACEUTICALS GMBH (DE) | 2023-05-04 | — | — | WO | disclosed |
| EP-4170347-A1 | GASTRIC INHIBITORY PEPTIDE RECEPTOR LIGANDS | 3B Pharmaceuticals GmbH (DE) | 2023-04-26 | — | — | EP | disclosed |